Clinical trials
Heart Valve Diseases trials in Germany with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 4 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Unknown status | 4 |
| Recruiting | 3 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Edwards Lifesciences | 7 |
| Abbott Medical Devices | 4 |
| JenaValve Technology, Inc. | 2 |
| Universitätsklinikum Hamburg-Eppendorf | 2 |
| Biotronik AG | 1 |
| Cardiovalve Ltd. | 1 |
| Charite University, Berlin, Germany | 1 |
| Claret Medical | 1 |
| Corcym S.r.l | 1 |
| Erasmus Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Valve Diseases | 32 |
| Aortic Valve Stenosis | 13 |
| Cardiovascular Diseases | 10 |
| Heart Diseases | 9 |
| Mitral Valve Insufficiency | 5 |
| Heart Failure | 4 |
| Tricuspid Valve Insufficiency | 4 |
| Aortic Valve Disease | 3 |
| Coronary Artery Disease | 3 |
| Aortic Diseases | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.